{"schemaVersion":"1.0.0","generatedAt":"2026-08-24T01:54:04.183Z","identity":{"ticker":"BCRX","name":"BIOCRYST PHARMACEUTICALS INC","cik":"0000882796","exchange":"Nasdaq","sector":"Healthcare","kind":"equity","tier":2,"liquidityRank":1945,"liquidityObservedAt":"2026-08-23T22:52:58.495Z","liquidityDollarVolume":23757831.05,"liquidityLastSale":9.55,"liquidityShareVolume":2487731,"marketCap":2440360253,"isUsListed":true,"sourceIds":["sec-tickers","nasdaq-symbol-directory","nasdaq-screener"]},"quote":{"last":9.55,"previousClose":9.55,"change":0,"changePct":0,"currency":"USD","volume":2487731,"observedAt":"2026-08-23T22:52:58.495Z"},"fundamentals":{"ticker":"BCRX","cik":"0000882796","annual":{"revenue":null,"dilutedEps":{"value":1.21,"start":"2025-01-01","end":"2025-12-31","period":"CY2025","accessionNumber":"0001628280-26-012240","filingUrl":"https://www.sec.gov/Archives/edgar/data/882796/000162828026012240/0001628280-26-012240-index.html","concept":"EarningsPerShareDiluted","unit":"USD-per-shares","sourceUrl":"https://data.sec.gov/api/xbrl/frames/us-gaap/EarningsPerShareDiluted/USD-per-shares/CY2025.json"}},"quarterly":{"revenue":null,"dilutedEps":{"value":0.3,"start":"2026-04-01","end":"2026-06-30","period":"CY2026Q2","accessionNumber":"0001628280-26-053300","filingUrl":"https://www.sec.gov/Archives/edgar/data/882796/000162828026053300/0001628280-26-053300-index.html","concept":"EarningsPerShareDiluted","unit":"USD-per-shares","sourceUrl":"https://data.sec.gov/api/xbrl/frames/us-gaap/EarningsPerShareDiluted/USD-per-shares/CY2026Q2.json"}}},"dividends":[],"seasonality":[],"news":[],"provenance":{"registry":"/data/machine/v1/universe/registry.json","framesGeneratedAt":"2026-08-23T22:53:06.919Z","quoteSourceUrl":"https://www.nasdaq.com/market-activity/stocks/screener","methodologyUrl":"https://dhawal.org/methodology/#coverage-tiers"},"limitations":[]}